Sean Ritchie is a Patent Attorney and member of the firm's Intellectual Property & Technology group. His practice focuses on intellectual property protection, including counseling clients on patent infringement, patentability, patent drafting, and patent prosecution. With an academic background in bioengineering, Sean's practice primarily focuses on chemical, life sciences, and materials science technologies. He also handles FDA compliance issues for medical devices.
Everyone's New Year's Resolution: More Privacy
Tennessee Bar Association, Corporate Counsel Section, Nashville, Tennessee, December 9, 2019
Patentability in the Context of Personalized Medicine, Novel Targets, Treatment Methods, and Repurposed Drugs
University of Kentucky, Office of Technology Commercialization, June 26, 2019
Battery-Powered Medical Devices Market Trends & Opportunities
Panel Member, Memphis, TN, May 7, 2019
Nashville Office Recruiting Committee, Member
Prior to joining Stites & Harbison in 2016, Sean was with McNees Wallace & Nurick LLC in Pennsylvania. Prior to that, he was in-house counsel for a biotechnology company where he focused on healthcare and medical device regulation. Sean is certified in neurophysiological introperative monitoring, and has spent time in the operating room monitoring somatosensory responses from patients during various vascular and neurological surgeries.
Time: 8:00 a.m. - 12:00 p.m.
Memphis Bioworks Foundation Auditorium, 20 Dudley Street #900, Memphis, TN 38103
IP attorney Sean Ritchie will join a panel of speakers discussing today's technological developments in medical diagnostics and prognostics at Memphis Bioworks Foundation in Memphis, Tennessee.
The patent process can be frustrating and often involves a significant investment of time and money. As such, it may be tempting to assume that when the Patent Office issues a patent it is safe to assert your rights therein. However, as noted in a recent decision from the District Court for the District of Delaware, doing so may leave you on the hook for attorney’s fees.
On January 7, 2019, the USPTO released updated guidance on how Patent Examiners should determine whether an invention is directed to subject matter that is eligible for patent protection under 35 U.S.C. § 101.
There are several different kinds of intellectual property protection (e.g., trademarks, patents, and copyrights). The borders between the types of protection are not always clear, and it may be that some subject matter is eligible for protection in more than one category.